Abstract
This study compared the ability of Nanostructured Lipid Carrier (NLC), Solid Lipid Nanoparticles (SLN), and Cream systems in delivering para Methoxycinnamic Acid (PMCA) to the dermis layer of the skin. Wistar rats were used as research subjects. NLC and SLN were made by applying the high shear homogenization method. Nile red was used as a penetration indicator based on its fluorescence. The interaction between fluorescence labeled NLC, SLN, or Cream and rat skin was visualized by fluorescence microscopy. Observations were made after 2 and 4.5 h of smearing the test sample. From the observations, it was known that the system/lipid base could penetrate the stratum corneum for delivering drugs. Penetration speed differs among systems as does the number of PMCAs that can be delivered. In this study, it can be concluded that the NLC system is able to deliver PMCA more quickly and in greater quantities to the dermis than SLN and Cream.
Similar content being viewed by others
Introduction
Topical preparation is a drug preparation in which its administration system is intended to be used on the skin1. The advantage of topical preparation is that it can avoid first-pass metabolism, reduce side effects caused by oral use, and improve patient compliance2.
On its development, conventional topical preparation has a problem, namely low permeation3 or low uptake due to barrier function of the stratum corneum5, thus a proper delivery system right to the place of action is needed. One of them is Lipid nanoparticle system. Lipid nanoparticle system is a semi-solid emulsion system with nano-size particles, which can be made by the application of high shear homogenization or high pressure homogenization method.
This drug delivery system is characterized by its matrix components consisting of single solid lipid or mixed lipid6. According to Khezri et al. (2018), topical preparation containing lipid nanoparticle has advantages, such as increasing the penetration of active substances into the skin so that it can increase effectiveness. The occlusive nature of this system enhances the hydration effect and the skin elasticity due to the small size of the lipid (nanoparticle) can form a lipid layer above the skin surface so that more water in the skin is retained4. This causes a reduction in the corneocyte wrapping, therefore the size of the corneocyte gap increases, and then more drugs will be absorbed4. There are two generations of Lipid nanoparticle, namely Solid Lipid Nanoparticle (SLN) and Nanostructured Lipid Carriers (NLC)5. According to Patel et al. (2019), both are safe as drug carriers via the topical route. SLN is made by replacing the oil from the o/w emulsion with solid lipid that is safe for the body8. Meanwhile, NLC has a composition consisting of a mixture of solid lipid and liquid lipid. NLC which its composition consists of a mixture of solid and liquid lipids can cause the formation of an imperfect lipid matrix so that the drug is loaded more9. The difference in composition between SLN and NLC causes NLC to have an advantage over SLN, which is higher drug entrapment but lower active ingredient pressure, so that the stability of NLC is better than SLN3,9. The choice of composition between solid lipid and liquid lipid in the NLC system is an important factor in drug entrapment that will affect drug release and penetration. In addition, with the nanoparticle size and spherical shape that NLC has, it can increase drug penetration into the skin11 and will produce a fast penetration rate at the beginning. NLC with a high entrapment value will produce a slow but constant penetration rate. Topical drug targeting the dermis must be able to penetrate the stratum corneum in which the drug will then interact with the target receptor. For this reason, it is necessary to carry out a penetration test.
This research used p- Methoxycinnamic Acid (PMCA) as the active agent with NLC delivery system. APMS is a biologically active compound resulting from the hydrolysis of Ethyl p- Methoxycinnamate (EPMS) derived from the Kaempferia galanga or aromatic ginger12. PMCA penetration is affected by the stratum corneum12, so that for the PMCA formulation it is necessary to add enhancers, or choose a drug delivery system that can affect the stratum corneum, such as NLC. In this study, the lipid components used are cetyl alcohol and oleic acid. These types of lipids affect the character of SLN or NLC. According to the research conducted12, cetyl alcohol can produce SLN with a smaller size and more spherical shape than stearic acid and can increase drug entrapment. Oleic acid as a liquid lipid can increase in vivo Trans Epidermal Water Loss (TEWL) and transport the drug to the subcutaneous intercellular area15. In the research done by Hu16, NLC with solid lipid stearic acid and oleic acid (liquid lipid) shows faster drug release than NLC without oleic acid.
In this research, penetration test of PMCA will be carried out with the ratio of NLC composition used of cetyl alcohol and oleic acid is (85%: 15%) of the total lipid in the formula. This was based on a research16, which states the addition of oleic acid up to 15% increases drug release with almost the same particle size distribution. The addition of liquid lipid will indirectly affect the absorption of the drug into the skin, thus it affects the penetration of the drug into the skin. In the SLN and NLC systems, it was reported that the controlled release caused by the burst released of the drug can increased the penetration of the drug into the skin10.
The increasing of PMCA penetration in NLC was proven by comparing it with SLN system and simple cream. To find out how the penetration effectiveness of the NLC system in the skin, the fluorescent label included in the formula was used and observed using a fluorescent microscope. The fluorescent label used was nile red, which is lipophilic17.
Results and discussion
Particle size
The results of the particle size examination (Table 1) showed that all formulas were included within the nanoparticle size range, which was 10-500nm18 and obtained the particle size of NLC PMCA < SLN PMCA < PMCA cream. This was because there was a liquid lipid in the NLC PMCA formula, namely oleic acid which could help the solubility of PMCA so that the resulting particle size was smaller.
From the PI values showed that the NLC base was most homogeneous compared to others, while PMCA_NLC was more homogeneous than PMCA_SLN. This might be caused by the addition of liquid lipids in the PMCA_NLC that dissolve PMCA.
pH formula measurement
The pH of the APMS, SLN APMS, and NLC APMS cream formulas in Table 2 in accordance with the pH skin range of 4–619.
Entrapment efficiency (EE)
Previously, a homogeneity test was performed to determine the uniformity of levels carried out for each replication conducted. Based on the results of the recovery test, it was known that the recovery of each repeatability formula was good because the recovery value of each formula met the requirements, namely 85–115%20. In addition, this method was considered to have good repeatability because of the small % CV.
From the results of the determination of EE, obtained data that can be seen in Fig. 1. The NLC PMCA formula had greater entrapment efficiency. The addition of liquid lipids in the formula affected the imperfections of the crystal lattice so that during solidification of the lipid phase, many drugs were trapped in the system21. Besides, it can also leave enough space for drug placement and drug entrapment16.
The data were analysed statistically with T-test sample method, it obtained the value of α sig. 2 tailed counts (0.028) < 0.05. It indicated that there was a significant difference and the Entrapment Efficiency of PMCA_NLC was greater than PMCA_SLN.
Occlusivity
The results of the occlusivity test of each formula is provided in histogram of the average occlusivity for one week from the various formulas which can be seen in Fig. 2. PMCA_NLC had greater occlusivity than PMCA_SLN and PMCA_Cream. This was because PMCA_NLC had the smallest particle size and the most homogen particle size. Small particle size could cause the structure between particles to be tight, causing an increased occlusivity, and small particle size caused the surface area of particles in contact with the skin to increase22. The presence of occlusivity caused the skin hydration increased. Moreover, hydration of the stratum corneum affected the rate of substance penetration into the skin.
The occlusivity data were analyzed using one-way Annova statistics. A calculated α value (0.00) < 0.05 indicated that there was a significant difference. Then proceed with the HSD Tukey test. The results showed there was a significant difference between the formulas. In this study, the largest occlusiveness was PMCA_NLC.
Penetration test on rat skin
On the penetration test, nile red was used as a fluorescent label because of its lipophilic nature23, otherwise known as lipophilic dye. As can be seen in Figs. 3 and 4, the NLC base in the first 2 h penetrated deeply into the dermis layer. This proved that the NLC base penetrated deeply into the skin layer, as well as PMCA in cream, SLN and NLC. This was because Cream, SLN, and NLC are lipid-base colloid carriers. Lipid-containing carrier system is a good drug delivery system for the skin because it can facilitate penetration, act on the skin surface, repair adhesiveness, and increase the hydration of corneocytes in the stratum corneum9.
The depth of penetration of the three formulas were compared over time (Fig. 4 and Table 3). After the application for 2 h, PMCA SLN penetrated deeper than PMCA NLC and PMCA Cream. This was predicted to occur due to the effect of differences of lipid crystal modification in SLN and NLC. Crystal modification causes less drug entrapment in SLN than in NLC, so that the amount of drug in the outer phase of the SLN was more than that in the NLC. This result has also happened in a research24 which indicates that the crystalline modification of the SLN matrix forces the drug out to the outer phase and accelerates penetration. Meanwhile, after the application for 4.5 h, NLC PMCA penetrated deeper compared to PMCA SLN and PMCA Cream. The results were different with the 2 h result. These differences could be caused by various factors that affect drug penetration into the skin such as occlusivity, particle size, drug concentration, and the effect of carrier materials25. The difference in PMCA NLC and PMCA Cream was more influenced by particle size. The small particle size and the spherical shape of the particles cause the inter-particle structure to be tight, causing an increased occlusivity (water retained in the stratum corneum caused hydration and swelling of corneocyte cells in the stratum corneum layer), so that drug substances could enter easily26. The difference between PMCA NLC and PMCA SLN was due to the addition of oleic acid as a liquid lipid, which also has other functions, namely as a penetration enhancer25 and PMCA solubilizing agent. The function of oleic acid as a penetration enhancer is to increase the drug transport to the subcutaneous intercellular area15. The increase of solubility of PMCA increased the diffusion coefficient PMCA to the skin membrane so that the drug penetrated better26. The fluorescence intensity measured qualitatively by observing the amount of drug delivered by Cream, SLN, and NLC to the skin layers, namely the stratum corneum, viable epidermis, and dermis. PMCA NLC could carry more drugs than PMCA SLN and PMCA Cream (Fig. 4.). Up to 4.5 h, the PMCA in the NLC system still had a fairly clear intensity red luminescence of nile in the dermis layer.
Methods and materials
The materials used in this study were p-methoxycinnamic acid (PMCA) from sigma Aldrich, cetyl alcohol, oleic acid, Tween 80 and propylene glycol from PT Brataco, Nile red from sigma Aldrich, isopropyl myristate (IPM), glacial acetic acid and sodium acetate with grades of quality from Merck index, and the distilled water from PT. Brataco.
Selection and treatment of animals
The experimental animals selected as research subjects were male white rats with Wistar strain (Rattus norvegicus). Male rats were selected to avoid the hormonal influence of the female. The rats used were 2–3 months old and weighted 200–300 g. The procedure for treating experimental animals in this study had received approval from the Research Ethics Commission of the Faculty of Veterinary Medicine, Universitas Airlangga (Certificate number 2.KE.016.02.2020). All methods were performed in accordance with ARRIVE guidelines and the relevant guidelines and regulations respectively.
Sample preparation
The test preparations in this study were PMCA NLC, NLC-Base, PMCA SLN, and PMCA Cream. PMCA NLC, NLC-Base, and PMCA SLN were made by applying high shear homogenization using Ultra Turrax T-25 at 24,000 rpm for 8 min in 4 cycles. At the same time, the manufacture of PMCA cream was made in a conventional way.
Characterization of SLN, NLC, and Cream
Particle size
The determination of particle size was carried out using the DelsaTM Nano Particle Analyzer. The data taken from this instrument was the average diameter of the particle size and polydisperty index.
pH measurement
The pH value of the preparation was measured using a pH meter by dispersing 1 g of sample into 10 mL of aquademineralisata.
Entrapment efficiency (EE)
The determination of EE in this study used the dialysis method. A portion of the dialysis media was taken and then its absorption was measured at the maximum wavelength of PMCA with a UV–Vis spectrophotometer to determine the amount of PMCA that was not trapped in the NLC. The blank used was the same NLC system with each formula without the addition of PMCA and prepared as same as the test sample. After that, it was calculated using the formula:
Notes:
Ct: PMCA concentration in NLC
Cf: PMCA concentration that are not entrapped
Viscosity
The viscosity of the preparation was measured using a Brookfield Cone and Plate HDV-I viscometer rate of share 20 rpm at 30 °C.
Occlusivity test
The occlusivity test was carried out using in vitro method. First of all, the empty vial was weighted and dried. Then, the vial that already contained 5 ml of water was weighted, closed using a filter membrane (cellulose filter, 0.45 mm pore, Whatman no. 4), and tied with a rope. After that, 10 drops of Isopropyl Myristate were added to saturate the membrane and left it overnight. After that, 0.05 g of the preparation to be tested was applied evenly to the membrane and then observed for a week. After a week, the amount of water that had been lost was calculated with the following formula:
Notes:
A = Amount of water lost in control
B = Amount of water lost in sample
F = Occlusivity
Penetration test on rat skin
On the early-stage skin penetration test, the rats were anesthetized by giving them ketamine of 20 mg/kg BW by intra muscular (im). The hair on the abdomen was shaved using mechanical hair clipper, then 50 mg of the test sample was applied to the stomach evenly. The part that had been smeared with the test sample was covered with a plastic cover and wrapped with a bandage so that not much of the test sample was lost and ensured that the test sample penetrated the skin layer well. After 2 and 4.5 h, the rats were sacrificed by cervical dislocation. The part of the skin that had been smeared with the sample was cut with an area of 1 × 4 cm2 then it was put on aluminum foil so it did not shrink and stored in the freezer at −80 °C. The skin that had been cut was then cut again using a frozen microtome with a thickness of 5 m. The finished preparation was then observed using a fluorescent microscope FSX100 OLYMPUS.
Furthermore, a qualitative analysis was carried out on the data obtained, namely the penetration distance of the test sample into the skin layer and the fluorescence intensity in each layer of the skin. Each layer of the skin was assessed for fluorescent intensity, namely: (-) No fluorescence, ( ±) Weak fluorescence, ( +) strong fluorescence, and (+ +) very strong Fluorescence27.
Conclusions
In this study, it can be concluded that the NLC drug delivery system can carry PMCA drugs to penetrate the dermis layer. In addition, the NLC system is able to increase drug penetration (PMCA) deeper compared to SLN and Cream as a delivery system.
Data availability
The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.
References
Ansel, H.C., Allen, L.V. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems, ninth Edition, (2011).
Castro, G. R., Larson, B. K., Panilaitis, B. & Kaplan, D. I. Emulsan quantitation by Nile red quenching fluorescence assay. Biotechnol. Products Process Eng. 67, 767–770 (2006).
Chauhan, I., Yasir, M., Verma, M. & Pratap Singh, A. Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Adv. Pharm. Bull. 10(2), 150–165 (2020).
Dragicevic, N., Krajisnik, D., Milic, J., Fahr, A. & Maibach, H. Development of hydrophilic gels containing coenzyme Q10-loaded liposomes: Characterization, stability and rheology measurements. Drug Dev. Ind. Pharm. 45(1), 43–54 (2019).
Dubey, A., Prabhu, P. & Kamath, J.V. Nano Structured lipid carriers: A Novel Topical drug delivery system, International Journal of PharmTech Research, 4(2): 705–714 (2012).
Guimmaraes KL, Nanocosmetics and Nanomedition. San Paulo: Spinger, 102–122 (2011).
Hu, F.-Q. et al. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloid Surf. 45, 167–173 (2005).
Jana, R. & Bhunıa, H. Thermal stability and proton conductivity of silane based nanostructured composite membranes. Solid State Ion 178(37–38), 1872–1878 (2008).
Jiang, S. J. et al. Structural and functional effects of oleic acid and iontophoresis on hairless mouse stratum corneum. J. Investig. Dermatol. 114(1), 64–70 (2000).
Khezri, K., Saeedi, M. & Dizaj, S. M. Application of nanoparticles in percutaneous delivery of active ingredients in cosmetic preparations. Biomed. Pharmacother. 106, 1499–1505 (2018).
Kaushik, V. et al. Influence of massage and skin hydration on dermal penetration efficacy of nile red from petroleum jelly-an unexpected outcome. Pharmaceutics 13(12), 1–20 (2021).
Lombardi Borgia, S. et al. Lipid nanoparticle for skin penetration enhancement-correlation to drug localization within particle matrix as determined by fluorescene and parelectric spectroscopy. J. Control. Release 110, 151–163 (2005).
Ministry of Research, Technology and Higher Education (DRPM – Kemenristekdikti) Indonesia
Mu, H. & Holm, R. Solid lipid nanocarriers in drug delivery: Characterization and design. Expert Opin. Drug Deliv. 15(8), 771–785 (2018).
Moser, K., Kriwet, K., Naik, A., Kalia, Y. N. & Guy, R. H. Passive skin penetration enhancement and its quantification in vitro. Eur. J. Pharm. Biopharm. 52, 103–112 (2001).
Patel, D. K., Kesharwani, R. & Kumar, V. Lipid nanoparticle topical and transdermal delivery: A review on production penetration mechanism to skin. Int. J. Pharm. Investig. 9(4), 148–153 (2019).
Rahmawan, T. G., Rosita, N. & Erawati, T. Characterısatıon of solıd lıpıd nanopartıcles p-methoxycınnamıc acıd (SLN-PMCA) formulated wıth dıfferent lıpıd component: stearıc acıd and cetyl alcohol. PharmaScientia 1(1), 23–29 (2012).
Santosa, M. H. Metabolisme Metabolit Sekunder Tumbuhan Obat Indonesia pada Kultur Sel Hepatosit Tikus Terisolasi (Laporan Penelitian Lembaga Penelitian Universitas Airlangga, 1997).
Sharma, A. & Baldi, A. Nanostructured lipid carriers: A review. J. Dev. Drugs. 7(1), 1–12 (2018).
Soeratri, W., Erawati, T., Rahmatika, D. & Rosita, N. Penentuan Dosis Asam p-metoksisinamat (APMS) Sebagai Antiinflamasi Topikal dan Studi Penetrasi APMS Melalui Kulit Tikus dengan dan Tanpa Stratum Korneum. Jurnal Farmasi dan Ilmu Kefarmasian Indonesia 1(1), 28–30 (2014).
Souto, E. B. et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert Opin. Drug Deliv. 17, 1–12 (2020).
van Kuijk-Meuwissen, M. E., Mougin, L., Junginger, H. E. & Bouwstra, J. A. Application of vesicles to rat skin in vivo: A confocal laser scanning microscopy study. J. Controlled Release 56(1–3), 189–196 (1998).
Waghule, T. et al. Current nanostructured pilid carriers as potential drug delivery systems for skin disorders. Pharm. Design 26(36), 4569–4579 (2020).
Walters, K. A. Dermatological and Transdermal Formulations 4th edn. (Marcel Dekker, Inc, 2002).
Wissing, S. & Muller, R. Solid lipid nanoparticles as carrier for suncreens: in vitro release and in vivo skin penetration. J. Control. Release 81, 225–233 (2002).
Wohlrab, J. et al. S2k guidelines for the use of topical preparations on the skin. J. German Soc. Dermatol. 16(3), 376–392 (2018).
Rowe RC, Sheskey PJ, Quinn ME, Handbook of Pharmaceutical Excipient. 6th Washington: the Pharmaceutical Press, (2009).
Author information
Authors and Affiliations
Contributions
N.R.: designed and conducted the research, performed data analysis, checked the manuscript, submitted the manuscript; A.A.S.: obtained the data, wrote the manuscript; D.M.H.: performed data analysis, provided feedback and suggestions for edits.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rosita, N., Sultani, A.A. & Hariyadi, D.M. Penetration study of p-methoxycinnamic acid (PMCA) in nanostructured lipid carrier, solid lipid nanoparticles, and simple cream into the rat skin. Sci Rep 12, 19365 (2022). https://doi.org/10.1038/s41598-022-23514-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-23514-0